Trials / Completed
CompletedNCT01045525
Phlebotomy and Lifestyle and Diet Advices vs Lifestyle and Diet Advices Only in Patients With Dysmetabolic Liversiderosis
Prospective Randomized Study Comparing the Effect of Phlebotomy and Lifestyle and Diet Advices vs Lifestyle and Diet Advices Only on Glycemia in Patients With Dysmetabolic Liversiderosis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 274 (actual)
- Sponsor
- Rennes University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Insulin resistance-associated hepatic iron overload (IR-HIO), also defined as dysmetabolic iron overload syndrome or dysmetabolic liversiderosis, is a common cause or iron overload in France, mainly in middle-age patients with increased serum ferritin levels associated with normal serum transferrin saturation, and normal serum iron concentration in the absence of other known cause of increased serum ferritin levels. Treatment includes a combination of dietary measures and physical activity to correct metabolic disorders. Phlebotomies seem to be beneficial when serum ferritin level is high. This study aims at comparing the effect of iron depletion (by phlebotomy) plus lifestyle and diet advices versus lifestyle and diet advices alone on blood glucose level and insulin sensitivity in subjects with IR-HIO in order to assess the benefits of phlebotomies on the reduction of risk of diabetes and cardiovascular associated complications.
Detailed description
Non applicable
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Phlebotomy | From 300 to 400mL for women; From 350 to 450mL for men |
| BEHAVIORAL | Lifestyle and diet advices | 2 Booklets with Dietary and physical activity advices |
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2015-06-01
- Completion
- 2015-12-01
- First posted
- 2010-01-11
- Last updated
- 2023-05-23
Locations
5 sites across 1 country: France
Source: ClinicalTrials.gov record NCT01045525. Inclusion in this directory is not an endorsement.